F. Spreafico

1.2k total citations
55 papers, 906 citations indexed

About

F. Spreafico is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, F. Spreafico has authored 55 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 20 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in F. Spreafico's work include Immune Cell Function and Interaction (10 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). F. Spreafico is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). F. Spreafico collaborates with scholars based in Italy, United Kingdom and Netherlands. F. Spreafico's co-authors include Alberto Mantovani, A. Vecchi, Maria Grandi, Walter Luini, Silvio Garattini, Enrico Pesenti, Aldo Tagliabue, Marina Sironi, Francesco Sola and Nicola Mongelli and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Analytical Biochemistry and Oncogene.

In The Last Decade

F. Spreafico

53 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Spreafico Italy 16 357 294 229 157 96 55 906
Eric Mas France 24 885 2.5× 378 1.3× 336 1.5× 102 0.6× 59 0.6× 60 1.7k
M K Bijsterbosch Netherlands 17 577 1.6× 87 0.3× 220 1.0× 141 0.9× 55 0.6× 27 1.1k
Maria Paprocka Poland 18 408 1.1× 232 0.8× 151 0.7× 121 0.8× 71 0.7× 54 936
Andrew G. Bosanquet United Kingdom 18 382 1.1× 303 1.0× 147 0.6× 60 0.4× 36 0.4× 45 974
E. Schlick United States 16 312 0.9× 204 0.7× 327 1.4× 52 0.3× 29 0.3× 51 968
Glen C. Todd United States 14 361 1.0× 395 1.3× 33 0.1× 121 0.8× 46 0.5× 24 1.0k
H. Wessels Netherlands 20 505 1.4× 177 0.6× 100 0.4× 50 0.3× 18 0.2× 62 1.5k
Sarah R. Klein United States 12 406 1.1× 674 2.3× 506 2.2× 104 0.7× 85 0.9× 21 1.4k
Peter R. Twentyman United Kingdom 22 787 2.2× 884 3.0× 61 0.3× 107 0.7× 71 0.7× 48 1.5k
Celia Vélez Spain 14 321 0.9× 181 0.6× 57 0.2× 55 0.4× 128 1.3× 55 717

Countries citing papers authored by F. Spreafico

Since Specialization
Citations

This map shows the geographic impact of F. Spreafico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Spreafico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Spreafico more than expected).

Fields of papers citing papers by F. Spreafico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Spreafico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Spreafico. The network helps show where F. Spreafico may publish in the future.

Co-authorship network of co-authors of F. Spreafico

This figure shows the co-authorship network connecting the top 25 collaborators of F. Spreafico. A scholar is included among the top collaborators of F. Spreafico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Spreafico. F. Spreafico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Facchinetti, Valeria, R. Lopa, F. Spreafico, et al.. (2000). Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1. Oncogene. 19(34). 3931–3940. 13 indexed citations
2.
Pesenti, Enrico, Francesco Sola, Nicola Mongelli, Maria Grandi, & F. Spreafico. (1992). Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity. British Journal of Cancer. 66(2). 367–372. 103 indexed citations
3.
Ripamonti, Marina, Gabriella Pezzoni, Enrico Pesenti, et al.. (1992). In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells. British Journal of Cancer. 65(5). 703–707. 44 indexed citations
4.
Duncan, Ruth, Leonard W. Seymour, Stephen R. Wedge, et al.. (1992). Preclinical evaluation of polymer-bound doxorubicin. Journal of Controlled Release. 19(1-3). 331–346. 158 indexed citations
5.
Sozzani, Silvano, et al.. (1990). In vivo effects of cyclosporin A on murine B-cells responding to type III pneumococcal polysaccharide. International Journal of Immunopharmacology. 12(4). 359–364. 1 indexed citations
6.
Malabarba, Adriano, F. Spreafico, Pietro Ferrari, et al.. (1989). Dechloro teicoplanin antibiotics.. The Journal of Antibiotics. 42(11). 1684–1697. 8 indexed citations
7.
Sozzani, Silvano, Francesco D’Alessandro, F. Capsoni, et al.. (1988). In vitro modulation of human monocytes functions by RU 41740 (biostsm®). International Journal of Immunopharmacology. 10(2). 93–102. 19 indexed citations
8.
Spreafico, F.. (1988). IMMUNOTOXICOLOGY IN 1987: PROBLEMS AND CHALLENGES. Fundamental and Clinical Pharmacology. 2(4). 353–367. 1 indexed citations
9.
Sozzani, Silvano, et al.. (1986). The effect of Biostim® (RU 41.740) on natural killer activity in different mouse organs. International Journal of Immunopharmacology. 8(8). 845–853. 13 indexed citations
10.
Filippeschi, Stefania, et al.. (1985). The antineoplastic activity of 4'-deoxydoxorubicin in murine solid tumors.. PubMed. 4(6). 425–9. 1 indexed citations
11.
Filippeschi, Stefania, et al.. (1984). The antineoplastic activity of hexaziridinocyclotriphosphazene (Myko 63) in murine tumors.. PubMed. 3(6). 425–9. 3 indexed citations
12.
Mantovani, Alberto, A. Vecchi, Walter Luini, et al.. (1980). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on macrophage and natural killer cell-mediated cytotoxicity in mice.. PubMed. 32(4). 200–4. 33 indexed citations
13.
Conti, Gabriella, et al.. (1980). Effect of cytotoxic agents on suppressor cells in mice. European Journal of Cancer (1965). 16(1). 53–58. 8 indexed citations
14.
Atassi, Ghanem, et al.. (1980). Antitumoral effect in mice of a new triepoxyde derivative: 1, 3, 5-triglycidyl-S-triazinetrione (NSC 296934). European Journal of Cancer (1965). 16(12). 1561–1567. 16 indexed citations
15.
Vecchi, A., et al.. (1978). Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerate.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(1). 111–7. 20 indexed citations
16.
Martini, Alessandro, M.G. Donelli, Alberto Mantovani, et al.. (1977). Antineoplastic Activity and Pharmacokinetics of Adriamycin and Daunomycin in Tumor Bearing Mice. Oncology. 34(4). 173–178. 14 indexed citations
17.
Mantovani, Alberto, Nadia Polentarutti, Giulio Alessandri, et al.. (1977). Activation of K cells in mice with transplanted tumours differing in immunogenicity and metastasizing capacity. British Journal of Cancer. 36(4). 453–460. 7 indexed citations
18.
Vecchi, A., Alberto Mantovani, Aldo Tagliabue, & F. Spreafico. (1976). A characterization of the immunosuppressive activity of adriamycin and daunomycin on humoral antibody production and tumor allograft rejection.. PubMed. 36(4). 1222–7. 36 indexed citations
19.
Mantovani, Alberto, Aldo Tagliabue, A. Vecchi, & F. Spreafico. (1976). Effects of adriamycin and daunomycin on spleen cell populations in normal and tumor allografted mice. European Journal of Cancer (1965). 12(5). 381–387. 19 indexed citations
20.
Mantovani, Alberto, et al.. (1975). <italic>Brief Communication:</italic> The Attacker: Target-Cell Ratio and Serum Effects on In Vitro Cell-Mediated Immunity. JNCI Journal of the National Cancer Institute. 55(2). 483–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Mas Breakdown of academic impact, for papers by M K Bijsterbosch Breakdown of academic impact, for papers by Maria Paprocka Breakdown of academic impact, for papers by Andrew G. Bosanquet Breakdown of academic impact, for papers by E. Schlick Breakdown of academic impact, for papers by Glen C. Todd Breakdown of academic impact, for papers by H. Wessels Breakdown of academic impact, for papers by Sarah R. Klein Breakdown of academic impact, for papers by Peter R. Twentyman Breakdown of academic impact, for papers by Celia Vélez
Rankless by CCL
2026